Simcere Pharmaceutical Group Limited (HKG: 2096)
Hong Kong
· Delayed Price · Currency is HKD 6.60
0.00 (0.00%)
Oct 10, 2024, 4:08 PM HKT
Simcere Pharmaceutical Group Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 6,340 | 6,608 | 6,324 | 5,000 | 4,509 | 5,037 | Upgrade
|
| Revenue Growth (YoY) | -9.51% | 4.49% | 26.49% | 10.89% | -10.48% | 11.57% | Upgrade
|
| Cost of Revenue | 1,455 | 1,624 | 1,327 | 1,080 | 899.93 | 888.49 | Upgrade
|
| Gross Profit | 4,885 | 4,984 | 4,997 | 3,920 | 3,609 | 4,148 | Upgrade
|
| Selling, General & Admin | 2,737 | 2,856 | 2,849 | 2,403 | 1,982 | 2,368 | Upgrade
|
| Research & Development | 1,353 | 1,563 | 1,728 | 1,417 | 1,142 | 716.41 | Upgrade
|
| Other Operating Expenses | -139.64 | -144.62 | -172.81 | -149.51 | -114.96 | -91.51 | Upgrade
|
| Operating Expenses | 3,949 | 4,273 | 4,390 | 3,686 | 3,009 | 2,993 | Upgrade
|
| Operating Income | 935.62 | 710.84 | 606.34 | 233.33 | 599.91 | 1,155 | Upgrade
|
| Interest Expense | -39.88 | -34.57 | -34.41 | -70.85 | -133.73 | -115.96 | Upgrade
|
| Interest & Investment Income | 49.44 | 54.96 | 59.87 | 68.29 | 26.25 | 34.72 | Upgrade
|
| Earnings From Equity Investments | 8.04 | 7.84 | 0.19 | -44.19 | -14.27 | -8.26 | Upgrade
|
| Currency Exchange Gain (Loss) | -32.43 | -13.28 | -57.22 | 116.01 | -46.23 | -1.63 | Upgrade
|
| EBT Excluding Unusual Items | 920.79 | 725.79 | 574.78 | 302.6 | 431.94 | 1,064 | Upgrade
|
| Gain (Loss) on Sale of Investments | -1,978 | -744.82 | 113.11 | 697.19 | 473.9 | 21.06 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.53 | 791.92 | -10.57 | 402.02 | -1.81 | -3.48 | Upgrade
|
| Asset Writedown | -6.87 | -6.87 | - | - | - | - | Upgrade
|
| Legal Settlements | -25.09 | -25.99 | - | - | - | - | Upgrade
|
| Other Unusual Items | - | - | 208.94 | - | -98.94 | - | Upgrade
|
| Pretax Income | -1,089 | 740.04 | 886.25 | 1,402 | 805.09 | 1,082 | Upgrade
|
| Income Tax Expense | 12.84 | 26.09 | -40.48 | -97.12 | 140.8 | 78.19 | Upgrade
|
| Earnings From Continuing Operations | -1,102 | 713.95 | 926.73 | 1,499 | 664.29 | 1,004 | Upgrade
|
| Minority Interest in Earnings | - | 0.81 | 4.14 | 8.18 | 5.25 | - | Upgrade
|
| Net Income | -1,102 | 714.76 | 930.87 | 1,507 | 669.53 | 1,004 | Upgrade
|
| Net Income to Common | -1,102 | 714.76 | 930.87 | 1,507 | 669.53 | 1,004 | Upgrade
|
| Net Income Growth | - | -23.22% | -38.23% | 125.10% | -33.29% | 36.79% | Upgrade
|
| Shares Outstanding (Basic) | 2,575 | 2,609 | 2,611 | 2,609 | 2,393 | 2,345 | Upgrade
|
| Shares Outstanding (Diluted) | 2,575 | 2,609 | 2,620 | 2,611 | 2,393 | 2,345 | Upgrade
|
| Shares Change (YoY) | -1.94% | -0.45% | 0.35% | 9.14% | 2.03% | - | Upgrade
|
| EPS (Basic) | -0.43 | 0.27 | 0.36 | 0.58 | 0.28 | 0.43 | Upgrade
|
| EPS (Diluted) | -0.43 | 0.27 | 0.36 | 0.58 | 0.28 | 0.43 | Upgrade
|
| EPS Growth | - | -24.26% | -38.29% | 106.46% | -34.61% | 36.79% | Upgrade
|
| Free Cash Flow | 612.46 | -332.13 | 1,011 | -411.46 | -256.11 | 265.15 | Upgrade
|
| Free Cash Flow Per Share | 0.24 | -0.13 | 0.39 | -0.16 | -0.11 | 0.11 | Upgrade
|
| Dividend Per Share | 0.160 | 0.160 | 0.160 | 0.150 | 0.150 | - | Upgrade
|
| Dividend Growth | 0% | 0% | 6.67% | 0% | - | - | Upgrade
|
| Gross Margin | 77.05% | 75.43% | 79.01% | 78.40% | 80.04% | 82.36% | Upgrade
|
| Operating Margin | 14.76% | 10.76% | 9.59% | 4.67% | 13.31% | 22.94% | Upgrade
|
| Profit Margin | -17.39% | 10.82% | 14.72% | 30.14% | 14.85% | 19.93% | Upgrade
|
| Free Cash Flow Margin | 9.66% | -5.03% | 15.99% | -8.23% | -5.68% | 5.26% | Upgrade
|
| EBITDA | 1,149 | 925.12 | 815.38 | 422.45 | 758.55 | 1,261 | Upgrade
|
| EBITDA Margin | 18.13% | 14.00% | 12.89% | 8.45% | 16.82% | 25.04% | Upgrade
|
| D&A For EBITDA | 213.58 | 214.29 | 209.04 | 189.12 | 158.63 | 105.82 | Upgrade
|
| EBIT | 935.62 | 710.84 | 606.34 | 233.33 | 599.91 | 1,155 | Upgrade
|
| EBIT Margin | 14.76% | 10.76% | 9.59% | 4.67% | 13.31% | 22.94% | Upgrade
|
| Effective Tax Rate | - | 3.53% | - | - | 17.49% | 7.23% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.